SCHEMBL624975

SCHEMBL624975

OC(c1ccccn1)C1(c2ccc(F)cc2)CCOCC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV3 Q8NET8 2/20 0.52
NR1I2 O75469 1/20 0.48
GRIN2B Q13224 1/20 0.36
HDAC3 O15379 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
NPY5R Q15761 2/20 0.35
KDM4E B2RXH2 1/20 0.35
OPRM1 P35372 2/20 0.34
OPRD1 P41143 2/20 0.34
OPRK1 P41145 2/20 0.34
OPRL1 P41146 2/20 0.34
TP53 P04637 2/20 0.33
IDH1 O75874 1/20 0.33
LMNA P02545 1/20 0.33
ALOX15 P16050 1/20 0.33
ALOX12 P18054 1/20 0.33
PPP1CA P62136 1/20 0.33
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL625279 0.89 TRPV3 (0.53) TRPV3NR1I2HDAC3HDAC1HDAC2
SCHEMBL625858 0.88 TRPV3 (0.66) TRPV3NR1I2GRIN2BNPY5RKDM4E
SCHEMBL624516 0.87 TRPV3 (0.58) TRPV3NR1I2KDM4EOPRM1OPRD1
SCHEMBL625711 0.86 TRPV3 (0.55) TRPV3NR1I2HDAC3HDAC1HDAC2
SCHEMBL626324 0.86 TRPV3 (0.52) TRPV3NR1I2HDAC3HDAC1HDAC2
SCHEMBL625365 0.86 NR1I2 (0.51) TRPV3NR1I2KDM4EOPRM1OPRD1
SCHEMBL624525 0.83 NR1I2 (0.72) TRPV3NR1I2HDAC6
SCHEMBL626364 0.81 TRPV3 (0.80) TRPV3NR1I2HDAC1LMNAL3MBTL1
SCHEMBL14893638 0.79 NR1I2 (0.49) TRPV3NR1I2KDM4EOPRM1OPRD1
SCHEMBL14893888 0.77 NR1I2 (0.49) TRPV3NR1I2OPRM1OPRD1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116325392-B Wavelength-variable light source and control method thereof 日本电信电话株式会社 2025-05-30 CN claimed
CN-119094492-A Method for crossing network to penetrate local area network gateway 王博靖 2024-12-06 CN claimed
CN-114189491-B Method for backuping and restoring Exchange mail server without agent 成都傲梅科技有限公司 2023-07-21 CN claimed
CN-112929418-B Rapid IO high-speed communication method and system based on publish-subscribe 华东计算技术研究所(中国电子科技集团公司第三十二研究所) 2023-03-14 CN claimed
US-9156788-B2 TRPV3 modulators ABBVIE INC. (US) 2015-10-13 US claimed
EP-2603490-A1 NOVEL TRPV3 MODULATORS AbbVie Inc. (US) 2013-06-19 EP claimed
US-20130150409-A1 NOVEL TRPV3 MODULATORS ABBVIE INC. (US) 2013-06-13 US claimed
WO-2012019315-A1 NOVEL TRPV3 MODULATORS ABBOTT LABORATORIES (US) 2012-02-16 WO claimed
US-12481540-B2 Techniques for resource discovery while building data centers ORACLE INTERNATIONAL CORPORATION (US) 2025-11-25 US disclosed
WO-2025215454-A1 TASK PROCESSING METHOD AND SYSTEM, MODEL TRAINING TASK PROCESSING METHOD, AND COMPUTING DEVICE 云智能资产控股(新加坡)私人股份有限公司 2025-10-16 WO disclosed
CN-119315703-A Meteorological information-based power grid dynamic monitoring and early warning method, system and storage medium 广州极能信息技术有限公司 2025-01-14 CN disclosed
CN-119292974-A Method for transmitting and receiving big data through TSI721 in Linux system 华东计算技术研究所(中国电子科技集团公司第三十二研究所) 2025-01-10 CN disclosed
CN-119250191-A Knowledge graph construction method, device, equipment and medium based on artificial intelligence 中国平安财产保险股份有限公司 2025-01-03 CN disclosed
CN-119130525-A Sales policy generation method and device, program product and storage medium 中国建设银行股份有限公司 2024-12-13 CN disclosed
EP-2603490-A1 NOVEL TRPV3 MODULATORS AbbVie Inc. (US) 2013-06-19 EP disclosed
US-20130150409-A1 NOVEL TRPV3 MODULATORS ABBVIE INC. (US) 2013-06-13 US disclosed
US-20130131036-A1 NOVEL TRPV3 MODULATORS ABBVIE INC. (US) 2013-05-23 US disclosed
WO-2013062966-A2 NOVEL TRPV3 MODULATORS ABBVIE INC. (US) 2013-05-02 WO disclosed
WO-2013062964-A2 NOVEL TRPV3 MODULATORS ABBVIE INC. (US) 2013-05-02 WO disclosed
WO-2012019315-A1 NOVEL TRPV3 MODULATORS ABBOTT LABORATORIES (US) 2012-02-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130131036-A1 NOVEL TRPV3 MODULATORS TRPV3, TRPV4, TRPV5 TRPV3 1/4885NR1I2 210/4885GRIN2B 557/4885
US-20130150409-A1 NOVEL TRPV3 MODULATORS TRPV3, TRPV4, TRPV5 TRPV3 1/4885NR1I2 219/4885GRIN2B 622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.